Biotech startup uses nanoparticles to induce immune tolerance
More than 100 approved drugs in the U.S. warn of immune-related side effects on their labels. Countless others never make it onto shelves because of unwanted immune responses that can harm patients and limit the effectiveness of drug candidates. Most gene therapies, for instance, use viruses to enter a person’s cells and alter their DNA. But those viruses often elicit […]
Continue reading »